Immutep. Every tracked FinTwit mention of $IMMP, newest first. 4 mentions since the first on Mar 13, 2026. See the price chart.
March 2026 · 4 mentions
Mar 13
Jacob Plieth — Lung (not head & neck) was the right choice for $IMMP to pursue in phase 3, but it still failed. Stock -89%. Sory via @APEXONCO -> https://t.co/Y1ilGP5Aqq↗
Jacob Plieth — TBF though, at least $IMMP didn't go into phase 3 in head & neck. Still shows the perils of relying on ph2 data on small patient numbers https://t.co/KFwmmpAHSS↗
Mar 13
Jacob Plieth — I did try to warn you... $IMMP pivotal Tacti-004 trial is a bust.↗